Abstract #2740

Using MRI to assess changes in distribution and leakage of contrast media in murine mammary ducts after intra-ductal injection: intact ducts vs. ducts with in situ cancer

Erica Markiewicz¹, Xiaobing Fan¹, Devkumar Mustafi¹, Marta Zamora¹, Suzanne D. Conzen², and Gregory S Karczmar¹

¹Radiology, University of Chicago, Chicago, IL, United States, ²Medicine, Hematology/Oncology, University of Chicago, Chicago, IL, United States

Contrast media injected directly into mammary ducts clearly shows mammary gland structure with 3D-MRI. Development of in situ cancer causes changes in the leakage rates and contrast agent distribution in ductal lumens and surrounding tissue. Differences we describe here between FVB/N mice and the SV40Tag mammary cancer mouse model, indicate that in situ cancer significantly changes the permeability of the ductal epithelium. Information gained from imaging these glands following intra-ductal injection can be used to develop new MRI-detectable biomarkers for early detection of in situ cancer, improve understanding of mammary cancer biology, and guide the design of new therapy.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.